Thomas Foltynie

Vascular parkinsonism: a review of the precision and frequency of the diagnosis.

The heterogeneity of idiopathic Parkinson's disease.

A genome-wide screen for association in Hungarian multiple sclerosis.

A whole genome association study in multiple sclerosis patients from north Portugal.

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

The future challenges in Parkinson's disease.

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.

A genome wide linkage disequilibrium screen in Parkinson's disease.

The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.

Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD.

UCHL-1 is not a Parkinson's disease susceptibility gene.

No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease.

Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort.

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

No evidence for association between an MAOA functional polymorphism and susceptibility to Parkinson's disease.

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life-threatening dystonia.

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Association of the human leucocyte antigen region with susceptibility to Parkinson's disease.

Surgical management of Parkinson's disease.

Minimizing brain shift in stereotactic functional neurosurgery.

Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes.

Gene therapy: a viable therapeutic strategy for Parkinson's disease?

Improving targeting in image-guided frame-based deep brain stimulation.

Skewering the subthalamic nucleus via a parietal approach.

Deep brain stimulation for Gilles de la Tourette syndrome: a case series targeting subregions of the globus pallidus internus.

The natural history of treated Parkinson's disease in an incident, community based cohort.

Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson's disease.

Clinical safety of brain magnetic resonance imaging with implanted deep brain stimulation hardware: large case series and review of the literature.

A gamma band specific role of the subthalamic nucleus in switching during verbal fluency tasks in Parkinson's disease.

Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review.

MRI-guided subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense with surgery under local anaesthesia?

Urinary incontinence following deep brain stimulation of the pedunculopontine nucleus.

Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome.

Screening for VPS35 mutations in Parkinson's disease.

Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging.

Critical aspects of clinical trial design for novel cell and gene therapies.

Parkinson's disease, insulin resistance and novel agents of neuroprotection.

Understanding and prevention of "therapy-" induced dyskinesias.

Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Subthalamic nucleus activity optimizes maximal effort motor responses in Parkinson's disease.

Subthalamic nucleus gamma oscillations mediate a switch from automatic to controlled processing: a study of random number generation in Parkinson's disease.

Image-verified deep brain stimulation reduces risk and cost with no apparent impact on efficacy.

Deep brain stimulation as a treatment for chorea-acanthocytosis.

Frequency specific activity in subthalamic nucleus correlates with hand bradykinesia in Parkinson's disease.

The risk of hardware infection in deep brain stimulation surgery is greater at impulse generator replacement than at the primary procedure.

Image-guided and image-verified deep brain stimulation.

Exenatide and the treatment of patients with Parkinson's disease.

Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism.

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Commentary.

Adaptive deep brain stimulation in advanced Parkinson disease.

Pallidal stimulation for cervical dystonia does not correct abnormal temporal discrimination.

Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.

The factor structure of the UPDRS as an index of disease progression in Parkinson's disease.

Subthalamic nucleus local field potential activity during the Eriksen flanker task reveals a novel role for theta phase during conflict monitoring.

The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?

Phase dependent modulation of tremor amplitude in essential tremor through thalamic stimulation.

Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.

Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis.

Exenatide as a potential treatment for patients with Parkinson's disease: first steps into the clinic.

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson's Disease.

K27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach.

Midline frontal cortex low-frequency activity drives subthalamic nucleus oscillations during conflict.